STAT+: Bipartisan pair of senators calls on Congress to examine expensive new Alzheimer’s drug
WASHINGTON — Sens. Elizabeth Warren (D-Mass.) and Bill Cassidy (R-La.) want Congress to take a…
Author: STAT
STAT+: Arcus’ anti-TIGIT immunotherapy shows ‘encouraging’ tumor response, but likely leaves investors wanting more
Arcus Biosciences said Wednesday that a two-drug combination that includes an anti-TIGIT antibody delivered “encouraging…
Officials note ‘likely association’ between Covid-19 vaccines and rare heart condition in young people
U.S. scientists said Wednesday that there was a “likely association” between mRNA Covid-19 vaccines and…
STAT+: What the cancer research community can learn from the Covid-19 response
The Covid-19 pandemic’s rapid spread across the world demanded a quick, collaborative response. Now, experts…
Key Democrats slam FDA for failing to crack down on Juul and other e-cigarette makers
WASHINGTON — Congressional Democrats openly pressured acting Food and Drug Administration Commissioner Janet Woodcock to…
STAT+: Pharmalittle: Inside the FDA’s contentious Aduhelm approval; Peter Bach heading to liquid biopsy startup
Good morning! Elizabeth Cooney here, sitting in for Ed Silverman, who would no doubt be…
Opinion: Listen: Priscilla Chan on pediatric biology and research: ‘Children are not tiny adults’
For this week’s episode of the “First Opinion Podcast,” I spoke with Priscilla Chan, co-founder…
STAT+: Peter Bach, industry critic, joins company aiming to make blood tests to detect cancer
Peter Bach, well-known as a drug pricing researcher and pharma industry gadfly, is leaving academia…
Opinion: Health care is a human right in times of crisis. Why not every day?
Much of the world has settled the matter of whether health care ought to be…
Opinion: The quest for thermostable vaccines and other innovations during Covid-19
The unprecedented rapid development and distribution of Covid-19 vaccines worldwide has brought new visibility to…
Prenatal exposure to ultra-fine particles increases a child’s risk of asthma, study finds
When Rosalind Wright started analyzing data on prenatal exposure to air pollution in mothers and…
.jpg)
Newly disclosed FDA documents reveal agency’s unprecedented path to approving Aduhelm
Chastened after a decisively negative review from outside advisers, the Food and Drug Administration convened…
How the pandemic has reshaped collaboration — and competition — in science
For as long as people have pointed telescopes at the night sky and slipped drops…
STAT+: Teva to pay $925,000 to Mississippi to settle generic price-fixing charges
After years of controversy, Teva Pharmaceuticals (TEVA) agreed to pay $925,000 to the state of…
STAT+: Key science officials detail their plans for a new research agency — and Congress is getting closer to funding it
WASHINGTON — Two key federal health officials are pitching a new branch of the National…
STAT+: Powerful Democrat’s new drug pricing manifesto hints at a carveout for small biotechs
WASHINGTON — Sen. Ron Wyden (D-Ore.), the influential chair of the Senate Finance Committee, is…
The lonely quest to create a commission to investigate Covid-19
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…
Pervasive bias in algorithms, Pear’s SPAC, & an Amazon accelerator
You’re reading the web edition of Health Tech, STAT’s twice-weekly newsletter about how tech is…
.jpg)
STAT+: STAT+ Conversations: Can tech change in-home care for seniors?
Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. ET….
STAT+: Pharmalittle: Biogen isn’t the only company to make big bucks from its Alzheimer’s drug; EU extends Covid-19 vax export block
Hello, everyone, and how are you this morning? Some puffy clouds are hovering over the…
STAT+: Pear Therapeutics to go public in $1.6 billion SPAC merger
Barreling forward with its early momentum in the digital therapeutics market, Pear Therapeutics announced Tuesday…
Drug-resistant bacteria pose a growing threat. Can new antibiotics be developed fast enough to combat them?
In 2016, a landmark report was issued on the global problem of antimicrobial resistance. The…
Opinion: FDA should lead the way on new ALS treatments, not Canada and Europe
Following the Food and Drug Administration’s recent decision to give the green light to aducanumab,…
STAT+: Biogen isn’t the only drug company that will profit from the new Alzheimer’s drug Aduhelm
WASHINGTON — Biogen’s expecting to make billions from its newly approved Alzheimer’s drug Aduhelm. But…
STAT+: ‘It’s hard to know what’s trustworthy’: A new research effort aims to vet digital health data from wearables
Covid-19 upended the way clinical trials get done — and don’t get done. With in-person…
Watch: An unusual 30th birthday gift: Why I got a colonoscopy so young — and documented every step
The passing of Chadwick Boseman from colorectal cancer at the age of 43 devastated so…
Chadwick Boseman’s tragedy is America’s tragedy: In colorectal cancer hot spots, young men are dying at higher rates
Three months before “Black Panther” star Chadwick Boseman died from stage 4 colon cancer at…
STAT+: Cost-effectiveness studies for widely used Medicare Part D drugs are few and far between
As more emphasis is placed on the value of prescription medicines, a new study found…
STAT+: BIO’s chief on the FDA commissioner rumors, drug pricing, and IP rights
WASHINGTON — Everyone wants to know whether Michelle McMurry-Heath, the newly minted president of the…
STAT+: HHS withdraws 340B drug discount opinion amid lawsuits by pharma companies
After a defeat in federal court, the Department of Health and Human Services withdrew an…
STAT+: A popular algorithm to predict sepsis misses most cases and sends frequent false alarms, study finds
It was a win win. Hospitals needed to prevent patient deaths from sepsis, a complication…
STAT+: Pharmalittle: Glaxo CEO under fire ahead of investor meeting; CureVac not giving up on its Covid-19 vaccine
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Opinion: Why we need to simulate the entire U.S. health system
Facebook unveiled a remarkable piece of internal infrastructure in the spring of 2020. Called Web-Enabled…
How a new buddy system is helping health workers grapple with Covid’s toll
Sylvia Perry had mainly worked in primary care before the Covid-19 pandemic hit. But as…
‘Nobody is catching it’: Algorithms used in hospitals nationwide are rife with bias
The algorithms carry out an array of crucial tasks: helping emergency rooms nationwide triage patients, …
STAT+: Medical journal argues a drug maker’s libel suit is really a public relations campaign to chill research
File this under “Not every legal brief is eye-glazing.” Two months ago, Pacira Biosciences (PCRX)…
STAT+: European Union loses bid for faster deliveries of AstraZeneca Covid-19 vaccine
The European Union failed in its attempt to force AstraZeneca (AZN) to speed deliveries of…
STAT+: A California law that bans drug coupons failed to increase generic use
A California law that banned coupons for brand-name prescription drugs failed to significantly boost greater…
STAT+: Pharmalittle: Biden to spend $3 billion to develop Covid-19 pills; most Americans believe the new Alzheimer’s drug will be effective
And so, another working week will soon draw to a close. Not a moment too…
Opinion: 3D bioprinting can help end organ transplant waitlists — if the FDA stops delaying
Right now, more than 100,000 Americans are waiting for organ transplants. Due to a lack…
STAT+: Poll: Many Americans concerned about FDA approval process for Alzheimer’s drug
Two-thirds of Americans who are familiar with the details of the newly approved Alzheimer’s treatment…
Clinicians open their notes to patients in a grand experiment in medical care
When Glenda Thomas of Framingham, Mass., checked her doctors’ notes online after a recent infusion,…
STAT+: Athira Pharma CEO placed on leave amid allegations of altered images in her research papers
The chief executive of Athira Pharma, a biotech developing treatments for Alzheimer’s and other neurodegenerative…
STAT+: Billions spent on prescription drug ads may have increased Medicare spending
The large sums of money spent on advertising prescription drugs directly to consumers may have…
Listen: The Covid vaccine booster debate, 23andMe hits Wall Street, & biotech’s call of the decade
Is 23andMe a tech company? Do we really need booster shots of Covid-19 vaccines? And…
Opinion: Why a controversial decision won’t stop me from serving on FDA advisory committees
Last week’s controversial decision by the FDA to give aducanumab, Biogen’s Alzheimer’s drug, accelerated approval…
Gender bias toward men in patent awards results in less biomedical innovation for women, study suggests
Research has long shown that fewer patents are awarded to women than to men. Now…
STAT+: Scientists unshelve a decades-old antibiotic to fight a new foe — ovarian cancer
Ovarian cancer, which kills about 15,000 Americans every year, has historically been one of the…
Virtual Event: Biotech: Where are we now?
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET….
STAT+: Pharmalittle: CureVac Covid-19 shot was 47% effective in a trial; pricey brain cancer drug no longer covered by Medicare
Rise and shine, everyone, another busy day is on the way. Even so, there is…